Issue Date: March 1, 2010
Drug Firms Create Cancer Nonprofit
In an unusual move, Eli Lilly & Co., Merck & Co., and Pfizer are joining forces to tackle the most common cancers in Asia. The Asian Cancer Research Group (ACRG), a nonprofit, will create a publicly available pharmacogenomic cancer database in hopes that the information will speed the development of diagnostics and treatments for cancer.
Funding for the multi-million-dollar initiative will be provided equally by the three companies, . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society